Search Results

Pradaxa (dabigatran) is a prescription blood-thinning medication approved by the U.S. Food and Drug Administration (FDA) to reduce the risk of stroke in patients with non-valvular atrial fibrillation (AFib). Unlike Coumadin® (warfarin), an anticoagulant drug approved more than 60 years ago, Pradaxa doesn’t require monthly blood testing and lacks strict dietary guidelines. Despite these benefits, data suggests that patients taking (more...)

Blood-thinning drugs (anticoagulants) are used to decrease the blood’s ability to clot, which can help reduce the risk of heart attack, stroke, and arterial blockages in patients suffering from atrial fibrillation—or abnormal heart rhythms. For many years, the anticoagulant warfarin (marketed as Coumadin) was the only drug approved to treat atrial fibrillation. But a newer generation of blood thinner drugs—such (more...)